1.
Mangilipally S, Lingala D, Dusa J, S AT, Bogi N, Aeluka R, D P. Regulatory Pathways for Generic Antiviral Drugs: ANDA Requirements in the USA Compared With BRICS. Int J Life Sci Pharm Res [Internet]. 2026 Nov. 13 [cited 2026 Nov. 19];16(3):64-75. Available from: https://ijlpr.com/index.php/journal/article/view/2059